Lonza Inc. Closes Ireland Site as U.S. Manufacturing Issues Causes Shortage of Ipsen (IPN.PA)'s Increlex
5/1/2013 8:20:36 AM
More...
|
Active Biotech AB (BTPC) and Ipsen (IPN.PA) Update the Analysis Plan for the 10TASQ10 Trial Evaluating Tasquinimod in the Treatment of Prostate Cancer
4/25/2013 10:11:14 AM
More...
|
Ipsen (IPN.PA)’s First Quarter 2013 Sales
4/25/2013 8:14:44 AM
More...
|
Ipsen (IPN.PA) and Inspiration Biopharmaceuticals Complete Sale of Haemophilia Assets
3/21/2013 7:38:09 AM
More...
|
Christel Bories Joins Ipsen (IPN.PA) as Deputy CEO
2/27/2013 7:09:35 AM
More...
|
Ipsen (IPN.PA)'s 2012 Results and 2013 Financial Objectives
2/27/2013 6:23:16 AM
More...
|
Ipsen (IPN.PA) and Inspiration Biopharmaceuticals Announce Closing of the IB1001 Sale to Cangene Corporation (CC:CNJ)
2/20/2013 10:31:59 AM
More...
|
Ipsen (IPN.PA) Release: Eziclen® / Izinova® a New Product for Bowel Cleansing Successfully Completed European Decentralised Registration Procedure
2/7/2013 9:42:38 AM
More...
|
Ipsen (IPN.PA) Sells Hemophilia B Drug to Cangene Corporation (CC:CNJ)
2/6/2013 7:15:48 AM
More...
|
Ipsen (IPN.PA)’s Fourth Quarter and Full Year 2012 Sales
1/30/2013 6:09:59 AM
More...
|
|